CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Alkermes reinstated Buy at Truist on narcolepsy opportunity

Positive
AI Analysis

Summary

Truist reinstated coverage of Alkermes with a Buy rating, citing the company's opportunity in narcolepsy.

Importance:3/10
Sentiment:
0.50
analyst_ratingupgradenarcolepsy
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on October 16, 2026 6:31 PM

Read Original